Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study. [electronic resource]
Producer: 20100506Description: 240-7 p. digitalISSN:- 1525-1438
- Adenocarcinoma, Clear Cell -- drug therapy
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carboplatin -- administration & dosage
- Cisplatin -- administration & dosage
- Female
- Humans
- Irinotecan
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.